Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$1.49B |
| 2 |
Eli Lilly
LLY
|
$784M |
| 3 |
NVIDIA
NVDA
|
$544M |
| 4 |
Spotify
SPOT
|
$510M |
| 5 |
Kenvue
KVUE
|
$493M |
Top Sells
| 1 |
Adobe
ADBE
|
$1.02B |
| 2 |
Thermo Fisher Scientific
TMO
|
$698M |
| 3 |
Danaher
DHR
|
$657M |
| 4 |
Intuit
INTU
|
$622M |
| 5 |
Boston Scientific
BSX
|
$562M |
Sector Composition
| 1 | Technology | 21.36% |
| 2 | Financials | 17.98% |
| 3 | Healthcare | 14.07% |
| 4 | Industrials | 13.34% |
| 5 | Consumer Discretionary | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Ryman Hospitality Properties
RHP
$6.35B
| $1.42M | ﹤0.01% |
+15,300
| New | +$1.42M |
|
727
A-Mark Precious Metals
AMRK
$587M
| $1.41M | ﹤0.01% |
37,759
-889
| -2% | -$33.3K |
|
728
Dynavax Technologies
DVAX
$1.18B
| $1.41M | ﹤0.01% |
108,782
-2,562
| -2% | -$33.1K |
|
729
e.l.f. Beauty
ELF
$7.6B
| $1.37M | ﹤0.01% |
+12,009
| New | +$1.37M |
|
730
Preferred Bank
PFBC
$1.18B
| $1.36M | ﹤0.01% |
24,702
-583
| -2% | -$32.1K |
|
731
Idacorp
IDA
$6.77B
| $1.33M | ﹤0.01% |
13,003
-304
| -2% | -$31.2K |
|
732
Autohome
ATHM
$3.39B
| $1.29M | ﹤0.01% |
44,177
-104,301
| -70% | -$3.04M |
|
733
MiMedx Group
MDXG
$1.06B
| $1.26M | ﹤0.01% |
+190,139
| New | +$1.26M |
|
734
Arcus Biosciences
RCUS
$1.3B
| $1.23M | ﹤0.01% |
60,353
-1,422
| -2% | -$28.9K |
|
735
TC Energy
TRP
$53.9B
| $1.21M | ﹤0.01% |
29,867
| – | – |
|
736
TripAdvisor
TRIP
$2.05B
| $1.21M | ﹤0.01% |
73,076
+3,540
| +5% | +$58.4K |
|
737
Kennametal
KMT
$1.67B
| $1.2M | ﹤0.01% |
42,252
+2,047
| +5% | +$58.1K |
|
738
Cross Country Healthcare
CCRN
$462M
| $1.17M | ﹤0.01% |
41,538
-978
| -2% | -$27.5K |
|
739
Norwegian Cruise Line
NCLH
$11.6B
| $1.16M | ﹤0.01% |
53,285
-1,255
| -2% | -$27.3K |
|
740
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $1.14M | ﹤0.01% |
81,032
-1,909
| -2% | -$26.9K |
|
741
Fox Class B
FOX
$24.9B
| $1.14M | ﹤0.01% |
35,695
+1,274
| +4% | +$40.6K |
|
742
Arcturus Therapeutics
ARCT
$485M
| $1.12M | ﹤0.01% |
+39,207
| New | +$1.12M |
|
743
Catalyst Pharmaceutical
CPRX
$2.48B
| $1.11M | ﹤0.01% |
82,612
-1,945
| -2% | -$26.1K |
|
744
General Motors
GM
$55.5B
| $1.1M | ﹤0.01% |
28,548
-168,459
| -86% | -$6.5M |
|
745
Ionis Pharmaceuticals
IONS
$9.76B
| $1.09M | ﹤0.01% |
26,529
-624
| -2% | -$25.6K |
|
746
Boise Cascade
BCC
$3.36B
| $1.08M | ﹤0.01% |
11,992
-26,441
| -69% | -$2.39M |
|
|
ITOS
747
DELISTED
iTeos Therapeutics
ITOS
| $1.08M | ﹤0.01% |
81,241
-1,913
| -2% | -$25.3K |
|
748
Barclays
BCS
$69.1B
| $1.03M | ﹤0.01% |
131,152
-183,390
| -58% | -$1.44M |
|
749
Chevron
CVX
$310B
| $979K | ﹤0.01% |
6,221
+335
| +6% | +$52.7K |
|
750
Assured Guaranty
AGO
$3.91B
| $967K | ﹤0.01% |
17,323
-407
| -2% | -$22.7K |
|